We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$8.27B
AUM Growth
+$1.17B
(+17%)
Cap. Flow
+$791M
Cap. Flow
% of AUM
9.57%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
1,071
New
101
Increased
574
Reduced
272
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$299M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$268M |
| 3 |
Apple
AAPL
|
+$63.9M |
| 4 |
Microsoft
MSFT
|
+$62.6M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$61.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$189M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$111M |
| 3 |
Visa
V
|
+$56.7M |
| 4 |
Mastercard
MA
|
+$48.1M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$41.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.46% |
| 2 | Financials | 14.83% |
| 3 | Healthcare | 4.08% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Industrials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
726
DELISTED
Cadence Bank
CADE
| $436K | 0.01% |
22,509
-3,585
| -14% | -$76.6K |
|
|
SPPI
727
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $435K | 0.01% |
106,497
+50,983
| +92% | +$194K |
|
728
AnaptysBio
ANAB
$1.59B
| $434K | 0.01% |
29,435
+12,507
| +74% | +$226K |
|
729
Delta Air Lines
DAL
$60.2B
| $431K | 0.01% |
14,084
+930
| +7% | +$26.8K |
|
730
GoDaddy
GDDY
$11.2B
| $431K | 0.01% |
5,667
+2,136
| +60% | +$161K |
|
731
Ryder
R
$10.1B
| $426K | 0.01% |
10,089
-1,087
| -10% | -$43.9K |
|
732
West Pharmaceutical
WST
$24.5B
| $426K | 0.01% |
1,549
-5,057
| -77% | -$1.34M |
|
|
UCB
733
United Community Banks
UCB
$4.29B
| $425K | 0.01% |
25,091
+4,475
| +22% | +$80.5K |
|
734
Hope Bancorp
HOPE
$1.81B
| $423K | 0.01% |
55,718
+20,886
| +60% | +$175K |
|
735
Cathay General Bancorp
CATY
$4.27B
| $422K | 0.01% |
19,472
-1,897
| -9% | -$46.4K |
|
736
Anika Therapeutics
ANIK
$277M
| $421K | 0.01% |
11,891
+4,549
| +62% | +$164K |
|
|
HZNP
737
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $417K | 0.01% |
5,370
-1,117
| -17% | -$76.9K |
|
|
GAP
738
The Gap Inc
GAP
$7.38B
| $416K | 0.01% |
24,419
-23,013
| -49% | -$343K |
|
739
Royalty Pharma
RPRX
$25.3B
| $413K | 0.01% |
+9,823
| New | +$421K |
|
740
Boston Properties
BXP
$11.2B
| $408K | ﹤0.01% |
5,079
-39,339
| -89% | -$3.43M |
|
741
Matsons
MATX
$6.28B
| $404K | ﹤0.01% |
10,089
-1,087
| -10% | -$41K |
|
742
Ameris Bancorp
ABCB
$5.92B
| $398K | ﹤0.01% |
17,450
+105
| +0.6% | +$2.47K |
|
743
Elanco Animal Health
ELAN
$12.8B
| $391K | ﹤0.01% |
13,988
+77
| +0.6% | +$1.95K |
|
744
Jacobs Solutions
J
$16.4B
| $391K | ﹤0.01% |
+5,096
| New | +$372K |
|
745
Syndax Pharmaceuticals
SNDX
$1.7B
| $390K | ﹤0.01% |
+26,396
| New | +$402K |
|
746
Assembly Biosciences
ASMB
$503M
| $388K | ﹤0.01% |
+1,968
| New | +$496K |
|
|
MYOK
747
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $388K | ﹤0.01% |
2,846
+506
| +22% | +$53.8K |
|
748
W.P. Carey
WPC
$16.6B
| $387K | ﹤0.01% |
6,057
-35,721
| -86% | -$2.41M |
|
749
Coca-Cola
KO
$374B
| $384K | ﹤0.01% |
7,776
-9,860
| -56% | -$474K |
|
750
AAR Corp
AIR
$5.71B
| $382K | ﹤0.01% |
20,315
+2,026
| +11% | +$38.6K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Rafferty Asset Management held 1,071 positions worth $8.27B, up 17% from $7.1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Rafferty Asset Management deployed $791M of net new capital in Q3 2020, opening 101 new positions and adding to 574 existing holdings. Its largest new stake was INPHI CORPORATION: 63,139 shares worth $7.09M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $189M trimmed.
- Rafferty Asset Management's largest Q3 2020 buy was INPHI CORPORATION: 63,139 shares worth $7.09M.
- Rafferty Asset Management added most to VanEck Gold Miners ETF in Q3 2020, an estimated $299M increase.
- Rafferty Asset Management's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $189M.
- Rafferty Asset Management fully exited iShares Russell 1000 ETF in Q3 2020, selling an estimated $19.9M.
- Rafferty Asset Management's ten largest holdings make up 44% of its $8.27B portfolio in Q3 2020.
- Rafferty Asset Management opened 101 new positions and closed 122 in Q3 2020.
- Rafferty Asset Management's portfolio value rose 17% quarter-over-quarter to $8.27B.
Based on Rafferty Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.